Monopar Therapeutics Inc. Proceeds from Stock Options Exercised
Monopar Therapeutics Inc. (MNPR) reported Proceeds from Stock Options Exercised of $7.58 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-12
- Monopar Therapeutics Inc. proceeds from stock options exercised for the quarter ending 2026-06-30 was $7.58K, a 60.83% increase year-over-year.
- Monopar Therapeutics Inc. proceeds from stock options exercised for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Monopar Therapeutics Inc. proceeds from stock options exercised for the quarter ending 2025-12-31 was $544.80K.
- Monopar Therapeutics Inc. proceeds from stock options exercised for the quarter ending 2025-09-30 was $214.00.
- Monopar Therapeutics Inc. proceeds from stock options exercised for fiscal 2025 was $565.17K, a 672722.62% increase from fiscal 2024.
- Monopar Therapeutics Inc. proceeds from stock options exercised for fiscal 2024 was $84.00.
- Monopar Therapeutics Inc. proceeds from stock options exercised for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Monopar Therapeutics Inc. proceeds from stock options exercised for fiscal 2022 was $169.00, a 99.03% decline from fiscal 2021.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 9 month as first filed | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $7.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $7.58K 10-Q · filed 2026-08-12 | $552.38K derived: sum of 3 quarters · filed 2026-08-12 | $552.59K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $544.80K derived: sum of 2 quarters · filed 2026-05-14 | $545.01K derived: sum of 3 quarters · filed 2026-05-14 | $549.72K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $544.80K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $545.01K derived: sum of 2 quarters · filed 2026-03-27 | $549.72K derived: sum of 3 quarters · filed 2026-08-12 | $565.17K 10-K · filed 2026-03-27 | |
| 2025-09-30 | $214.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $4.92K derived: sum of 2 quarters · filed 2026-08-12 | $20.37K 10-Q · filed 2025-11-13 | $20.37K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $4.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $20.16K 10-Q · filed 2026-08-12 | $20.16K derived: sum of 3 quarters · filed 2026-08-12 | $20.16K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $15.45K 10-Q · filed 2026-05-14 | $15.45K derived: sum of 2 quarters · filed 2026-05-14 | $15.45K derived: sum of 3 quarters · filed 2026-05-14 | $15.53K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $84.00 derived: sum of 3 quarters · filed 2026-03-27 | $84.00 10-K · filed 2026-03-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $84.00 derived: sum of 2 quarters · filed 2025-11-13 | $84.00 10-Q · filed 2025-11-13 | $3.16M 10-Q · filed 2024-11-08 | -$1.69M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $84.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $84.00 10-Q · filed 2025-08-12 | -$1.69M derived: sum of 3 quarters · filed 2025-08-12 | $84.00 derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 | -$1.69M derived: sum of 2 quarters · filed 2025-05-13 | $0.00 derived: sum of 3 quarters · filed 2025-05-13 | ||
| 2023-12-31 | -$1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.69M 10-Q · filed 2024-11-08 | $0.00 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $128.00 derived: sum of 2 quarters · filed 2024-03-28 | $169.00 derived: sum of 3 quarters · filed 2024-03-28 | $169.00 10-K · filed 2024-03-28 | |
| 2022-09-30 | $128.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $169.00 derived: sum of 2 quarters · filed 2023-11-09 | $169.00 10-Q · filed 2023-11-09 | $169.00 derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $41.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $41.00 10-Q · filed 2023-08-10 | $41.00 derived: sum of 3 quarters · filed 2023-08-10 | $41.00 derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-03-23 | $0.00 derived: sum of 3 quarters · filed 2023-03-23 | $0.00 derived: sum of 4 quarters · filed 2023-03-23 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $0.00 derived: sum of 2 quarters · filed 2023-03-23 | $0.00 derived: sum of 3 quarters · filed 2023-03-23 | $17.48K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $17.48K 10-Q · filed 2022-11-10 | $17.48K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $17.48K 10-Q · filed 2022-08-11 | $17.48K derived: sum of 3 quarters · filed 2022-08-11 | $17.48K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $17.48K 10-Q · filed 2022-05-12 | $17.48K derived: sum of 2 quarters · filed 2022-05-12 | $17.48K derived: sum of 3 quarters · filed 2022-05-12 | $17.48K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $0.00 derived: sum of 2 quarters · filed 2022-03-24 | $0.00 derived: sum of 3 quarters · filed 2022-03-24 | $0.00 10-K · filed 2022-03-24 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-13 | ||||
| 2019-12-31 | $110.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |